Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
DexCom (DXCM) Accused of Misleading Investors - Hagens Berman
03:36pm, Monday, 26'th Aug 2024
SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons w
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
Class Action Announcement (DXCM): A Securities Fraud Class Action Lawsuit Was Filed Against Dexcom, Inc.
01:57pm, Monday, 26'th Aug 2024
RADNOR, PA / ACCESSWIRE / August 26, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United Stat
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
11:45am, Monday, 26'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
Contact Levi & Korsinsky by October 21, 2024 Deadline to Join Class Action Against DexCom, Inc. (DXCM)
11:15am, Monday, 26'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
DexCom Inc Is Being Investigated By The Schall Law Firm For Securities Law Infractions And Investors Are Encouraged To Reach Out
11:00am, Monday, 26'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. ("
Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
09:00am, Monday, 26'th Aug 2024
Dexcom will launch its new CGM before the end of the month. The move could help troubled Dexcom stock, which is under heavy pressure.
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
08:00am, Monday, 26'th Aug 2024
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
07:15am, Monday, 26'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK CITY, NY / ACCESSWIRE / August 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, I
Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
06:30am, Monday, 26'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Compan
Dexcom announces launch of over-the-counter continuous glucose monitor
06:12am, Monday, 26'th Aug 2024
Dexcom said on Monday its over-the-counter continuous glucose monitor Stelo is now available for use in the United States.
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
06:00am, Monday, 26'th Aug 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter gl
